Clinical trials
Recruiting Liver Cirrhosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
167 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 3 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 6 |
| 2021 | 12 |
| 2022 | 18 |
| 2023 | 25 |
| 2024 | 32 |
| 2025 | 34 |
| 2026 | 20 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 167 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Massachusetts General Hospital | 5 |
| Northern Jiangsu People's Hospital | 5 |
| The Cleveland Clinic | 4 |
| Assistance Publique - Hôpitaux de Paris | 3 |
| Institute of Liver and Biliary Sciences, India | 3 |
| Medical University of Vienna | 3 |
| Post Graduate Institute of Medical Education and Research, Chandigarh | 3 |
| Air Force Military Medical University, China | 2 |
| Boehringer Ingelheim | 2 |
| European Foundation for Study of Chronic Liver Failure | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Liver Cirrhosis | 167 |
| Fibrosis | 29 |
| Non-alcoholic Fatty Liver Disease | 24 |
| Carcinoma, Hepatocellular | 19 |
| Hypertension, Portal | 16 |
| Liver Diseases | 15 |
| Fatty Liver | 13 |
| Ascites | 10 |
| Sarcopenia | 10 |
| Hepatic Encephalopathy | 9 |
Trials
Showing 51 to 75 of 167. Each trial links to its page on Pharma Observatory.
67 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.